Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesNuclear MedicineLLMs rapidly evolving in nuclear medicineLarge language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.MRIDWI with fat correction identifies liver scarring in MASLD patientsUltrasoundGhost scans problematic in POCUS trauma examsMolecular ImagingPSMA-PET may require selective use to be cost-effectiveSponsor ContentJoin Us!
